Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors.
SGLT-2 抑制劑的罕見但嚴重副作用:正常血糖的糖尿病性酮酸中毒。
World J Cardiol 2022-11-08
Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient.
老年患者因 empagliflozin 引起的正血糖糖尿病性酮酸中毒並併發營養不良。
Arch Clin Cases 2023-06-15
A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor.
一例正常血糖糖尿病性酮酸中毒(DKA)、流感和二肽基肽酶-4(DPP-4)抑制劑的病例。
Cureus 2023-07-01
Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
SGLT-2 抑制劑治療後伴隨ST段抬高型心肌梗塞的正常血糖糖尿病性酮酸中毒。
Am J Emerg Med 2023-08-07
Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis.
44名患者的正糖尿病酮酸中毒經驗及與高血糖糖尿病酮酸中毒的比較。
West J Emerg Med 2024-01-04
The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage.
精確診斷糖尿病的重要性:一例因引入 Empagliflozin 同時減少胰島素劑量而誘發的正常血糖酮酸中毒症。
Eur J Case Rep Intern Med 2024-06-07